Journal of Pharmaceutical Policy and Practice (Dec 2015)
Highly innovative drugs in the Czech Republic: retrospective analysis of impact on early market entry, regular reimbursement system entry and public pharmaceutical expenditure
Abstract
No abstracts available.Keywords